Paxman AB (publ) (STO:PAX)

Market Cap	1.64B
Revenue (ttm)	263.20M
Net Income (ttm)	40.20M
Shares Out	20.91M
EPS (ttm)	2.11
PE Ratio	37.25
Forward PE	23.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,995
Average Volume	28,822
Open	78.00
Previous Close	78.00
Day's Range	77.40 - 78.60
52-Week Range	37.20 - 79.00
Beta	0.37
RSI	68.16
Earnings Date	Apr 25, 2025

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.